Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
Open Access
- 31 October 2012
- journal article
- research article
- Published by Wiley in Journal of Veterinary Internal Medicine
- Vol. 26 (6), 1337-1349
- https://doi.org/10.1111/j.1939-1676.2012.01026.x
Abstract
Background The benefit of pimobendan in delaying the progression of preclinical dilated cardiomyopathy (DCM) in Dobermans is not reported. Hypothesis That chronic oral administration of pimobendan to Dobermans with preclinical DCM will delay the onset of CHF or sudden death and improve survival. Animals Seventy-six client-owned Dobermans recruited at 10 centers in the UK and North America. Methods The trial was a randomized, blinded, placebo-controlled, parallel group multicenter study. Dogs were allocated in a 1:1 ratio to receive pimobendan (Vetmedin capsules) or visually identical placebo. The composite primary endpoint was prospectively defined as either onset of CHF or sudden death. Time to death from all causes was a secondary endpoint. Results The proportion of dogs reaching the primary endpoint was not significantly different between groups (P = .1). The median time to the primary endpoint (onset of CHF or sudden death) was significantly longer in the pimobendan (718 days, IQR 4411152 days) versus the placebo group (441 days, IQR 151641 days) (log-rank P = 0.0088). The median survival time was significantly longer in the pimobendan (623 days, IQR 4911531 days) versus the placebo group (466 days, IQR 236710 days) (log-rank P = .034). Conclusion and Clinical Importance The administration of pimobendan to Dobermans with preclinical DCM prolongs the time to the onset of clinical signs and extends survival. Treatment of dogs in the preclinical phase of this common cardiovascular disorder with pimobendan can lead to improved outcome.Keywords
This publication has 30 references indexed in Scilit:
- Use of Simpson's Method of Disc to Detect Early Echocardiographic Changes in Doberman Pinschers with Dilated CardiomyopathyJournal of Veterinary Internal Medicine, 2010
- Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical casesJournal of Small Animal Practice, 2010
- Efficacy of Benazepril Hydrochloride to Delay the Progression of Occult Dilated Cardiomyopathy in Doberman PinschersJournal of Veterinary Internal Medicine, 2009
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsJournal of the American College of Cardiology, 2009
- Effect of Pimobendan on Case Fatality Rate in Doberman Pinschers with Congestive Heart Failure Caused by Dilated CardiomyopathyJournal of Veterinary Internal Medicine, 2008
- Dilated cardiomyopathy: an updateVeterinary Clinics of North America: Small Animal Practice, 2004
- A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated CardiomyopathyJournal of Veterinary Internal Medicine, 2002
- Recommendations for Standards in Transthoracic Two‐Dimensional Echocardiography in the Dog and CatJournal of Veterinary Internal Medicine, 1993
- Factors influencing the one-year mortality of dilated cardiomyopathyThe American Journal of Cardiology, 1984